Nexalin Technology (NXL) Competitors $1.16 -0.03 (-2.52%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$1.25 +0.10 (+8.19%) As of 07/25/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NXL vs. MDAI, CTSO, ZYXI, HYPR, SURG, ICCM, EDAP, CTCX, ECOR, and RBOTShould you be buying Nexalin Technology stock or one of its competitors? The main competitors of Nexalin Technology include Spectral AI (MDAI), Cytosorbents (CTSO), Zynex (ZYXI), Hyperfine (HYPR), SurgePays (SURG), IceCure Medical (ICCM), Edap Tms (EDAP), Carmell (CTCX), electroCore (ECOR), and Vicarious Surgical (RBOT). These companies are all part of the "medical equipment" industry. Nexalin Technology vs. Its Competitors Spectral AI Cytosorbents Zynex Hyperfine SurgePays IceCure Medical Edap Tms Carmell electroCore Vicarious Surgical Nexalin Technology (NASDAQ:NXL) and Spectral AI (NASDAQ:MDAI) are both small-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, institutional ownership, dividends, analyst recommendations, valuation and risk. Is NXL or MDAI more profitable? Spectral AI has a net margin of -30.75% compared to Nexalin Technology's net margin of -6,529.77%. Spectral AI's return on equity of 0.00% beat Nexalin Technology's return on equity.Company Net Margins Return on Equity Return on Assets Nexalin Technology-6,529.77% -277.92% -245.37% Spectral AI -30.75%N/A -11.37% Do institutionals & insiders have more ownership in NXL or MDAI? 0.7% of Nexalin Technology shares are owned by institutional investors. Comparatively, 67.1% of Spectral AI shares are owned by institutional investors. 25.3% of Nexalin Technology shares are owned by company insiders. Comparatively, 30.7% of Spectral AI shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has stronger earnings and valuation, NXL or MDAI? Nexalin Technology has higher earnings, but lower revenue than Spectral AI. Spectral AI is trading at a lower price-to-earnings ratio than Nexalin Technology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNexalin Technology$170K117.23-$7.61M-$0.83-1.40Spectral AI$29.58M2.23-$15.31M-$0.54-4.81 Does the media refer more to NXL or MDAI? In the previous week, Nexalin Technology and Nexalin Technology both had 1 articles in the media. Nexalin Technology's average media sentiment score of 1.87 equaled Spectral AI'saverage media sentiment score. Company Overall Sentiment Nexalin Technology Very Positive Spectral AI Very Positive Do analysts recommend NXL or MDAI? Nexalin Technology presently has a consensus price target of $5.00, indicating a potential upside of 331.03%. Spectral AI has a consensus price target of $4.75, indicating a potential upside of 82.69%. Given Nexalin Technology's higher possible upside, equities analysts plainly believe Nexalin Technology is more favorable than Spectral AI.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nexalin Technology 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Spectral AI 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Which has more risk & volatility, NXL or MDAI? Nexalin Technology has a beta of 3.7, suggesting that its share price is 270% more volatile than the S&P 500. Comparatively, Spectral AI has a beta of 0.9, suggesting that its share price is 10% less volatile than the S&P 500. SummarySpectral AI beats Nexalin Technology on 10 of the 15 factors compared between the two stocks. Get Nexalin Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for NXL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NXL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXL vs. The Competition Export to ExcelMetricNexalin TechnologyTechnology Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$20.44M$2.50B$18.97B$9.50BDividend YieldN/A1.50%2.73%4.00%P/E Ratio-1.4030.8429.6020.08Price / Sales117.2339.8654.6199.95Price / CashN/A45.9727.3958.56Price / Book4.145.496.265.88Net Income-$7.61M$33.53M$197.98M$258.89M7 Day Performance6.42%2.02%1.50%3.70%1 Month Performance16.00%9.22%5.40%11.71%1 Year Performance-6.45%32.56%26.46%17.98% Nexalin Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXLNexalin Technology2.9937 of 5 stars$1.16-2.5%$5.00+331.0%-0.9%$20.44M$170K-1.403Positive NewsMDAISpectral AI3.77 of 5 stars$2.68-6.3%$4.75+77.2%+46.9%$67.86M$29.58M-4.9683CTSOCytosorbents1.6433 of 5 stars$1.05-0.9%$5.50+423.8%-8.4%$65.74M$35.33M-3.75220Gap UpZYXIZynex2.1255 of 5 stars$2.11-5.8%$6.00+184.4%-74.7%$63.81M$192.35M-8.79770HYPRHyperfine1.4401 of 5 stars$0.80+4.0%$1.06+32.5%-6.1%$62.27M$11.73M-1.48190News CoveragePositive NewsGap UpSURGSurgePays3.3122 of 5 stars$2.99-4.8%$9.00+201.0%-2.0%$61.03M$40.03M-1.0740ICCMIceCure Medical2.4449 of 5 stars$1.03-1.0%$2.50+142.7%+33.8%$60.46M$3.27M-3.6860News CoverageGap UpEDAPEdap Tms3.0597 of 5 stars$1.51-1.3%$8.50+464.8%-70.1%$56.28M$62.77M-2.43230Positive NewsCTCXCarmellN/A$2.68-3.2%N/A+306.0%$56.03M$32.84K0.0014ECORelectroCore3.2681 of 5 stars$7.45+8.3%$25.50+242.3%+29.2%$55.28M$25.18M-4.7850Positive NewsRBOTVicarious Surgical0.3729 of 5 stars$9.09+12.3%$8.50-6.4%+46.6%$53.88MN/A-0.87210Gap Down Related Companies and Tools Related Companies Spectral AI Alternatives Cytosorbents Alternatives Zynex Alternatives Hyperfine Alternatives SurgePays Alternatives IceCure Medical Alternatives Edap Tms Alternatives Carmell Alternatives electroCore Alternatives Vicarious Surgical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NXL) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredURGENT: Trump Could Buy 1,000,000 Bitcoins TOMORROW?According to one report, senior officials and crypto insiders recently discussed Bitcoin accumulation at the h...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nexalin Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nexalin Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
